A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19
Oliver J. McElvaney(University of Washington), Noel G. McElvaney(Royal College of Surgeons in Ireland), Dandi Qiao, Natalie McEvoy(Royal College of Surgeons in Ireland), Gerard F. Curley(Apple (Israel)), Seán Walsh(Beaumont Hospital), Matthew Moll(Brigham and Women's Hospital), Eoin O’Connor(Beaumont Hospital), Oisín F. McElvaney(Royal College of Surgeons in Ireland), Brian D. Hobbs(Brigham and Women's Hospital), Jennifer Clarke(Beaumont Hospital), Michael H. Cho(Brigham and Women's Hospital)
Cited by 107
Related Papers
Variants in FAM13A are associated with chronic obstructive pulmonary disease
|Nature Genetics|2010|423
<i>MMP12,</i> Lung Function, and COPD in High-Risk Populations
|New England Journal of Medicine|2009|375
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2019|343
Interleukin-6: obstacles to targeting a complex cytokine in critical illness
|The Lancet Respiratory Medicine|2021|264